Stock & Company Details
Cabaletta Bio Inc $CABA
Price:
N/A
N/A
170M
$258M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.81
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CABA technical indicators
Latest Cabaletta Bio Inc (CABA) indicator readings as of 2026-10-29.
CABA's 14-day RSI is 39.8, in neutral territory. At $1.58 it is trading 44.6% below its 200-day moving average of $2.86, and below its 50-day average of $2.34. Price sits in the middle of its Bollinger Bands ($1.22 to $2.13). ADX reads 41.2, indicating a trending market.
Overview
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.
Finance Bot
Ask your questions
Start by typing a question below.
